INmune Bio, Inc. (INMB) Misses Q2 EPS by 65c
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($1.05), $0.65 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.
INmune Bio, Inc. (NASDAQ: INMB) reported Q2 EPS of ($1.05), $0.65 worse than the analyst estimate of ($0.40).
For earnings history and earnings-related data on INmune Bio, Inc. (INMB) click here.